These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23773753)

  • 1. [Suspension of Diane35 and its generics: an over-reaction by the French National Medicines Agency (ANSM) unfounded in the light of proven or accepted medical knowledge].
    Debarre JM
    Ann Dermatol Venereol; 2013; 140(6-7):474-8. PubMed ID: 23773753
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral contraceptives, risks and hazards].
    Revuz J
    Ann Dermatol Venereol; 2014 Jan; 141(1):5-6. PubMed ID: 24461087
    [No Abstract]   [Full Text] [Related]  

  • 3. European Commission orders France to lift ban on acne pill.
    Arie S
    BMJ; 2013 Aug; 347():f4932. PubMed ID: 23918671
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Too much disclosure of product risks? CBC television, SOGC, and Diane-35.
    Mintzes B; Lexchin J; Lippman A; Ford AR
    J Obstet Gynaecol Can; 2003 Apr; 25(4):268-9; discussion 270-3. PubMed ID: 12679817
    [No Abstract]   [Full Text] [Related]  

  • 6. Diane-35 (cyproterone acetate): safety concerns.
    Wooltorton E
    CMAJ; 2003 Feb; 168(4):455-6. PubMed ID: 12591790
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
    Heuser P; Tonga K; Hopkins R; Henderson M; Weatherall M; Metcalfe S; Beasley R
    N Z Med J; 2004 Nov; 117(1206):U1176. PubMed ID: 15570345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive].
    Mehrl J
    Fortschr Med; 1988 Aug; 106(25):50-1. PubMed ID: 2971600
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyproterone acetate-ethinyl estradiol use in a 23-year-old woman with stroke.
    Kromm J; Jeerakathil T
    CMAJ; 2014 Jun; 186(9):690-3. PubMed ID: 24491473
    [No Abstract]   [Full Text] [Related]  

  • 10. First-use risks.
    Rowe TC
    CMAJ; 2003 May; 168(11):1394. PubMed ID: 12771065
    [No Abstract]   [Full Text] [Related]  

  • 11. Venous thrombosis with cyproterone (continued).
    Prescrire Int; 2004 Apr; 13(70):59. PubMed ID: 15148982
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
    Kaiser E
    Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):738-42. PubMed ID: 2948866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The hypocrisy of Diane®].
    Revuz J
    Ann Dermatol Venereol; 2013 Apr; 140(4):249-50. PubMed ID: 23567222
    [No Abstract]   [Full Text] [Related]  

  • 14. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study.
    Seaman HE; de Vries CS; Farmer RD
    Hum Reprod; 2003 Mar; 18(3):522-6. PubMed ID: 12615818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists].
    Vignini M; Pelfini C; Montanari L
    Minerva Ginecol; 1988 Feb; 40(2):125-32. PubMed ID: 2969466
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy of oral contraceptives on acne. Apropos of a comparative study of Varnoline vs Diane in 69 women with acne].
    Levrier M; Degrelle H; Bestaux Y; Bourry-Moreno M; Brun JP; Sailly F
    Rev Fr Gynecol Obstet; 1988; 83(7-9):573-6. PubMed ID: 2973646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
    Vaidya RA; Shringi MS; Vaidya AB; Gogate JG
    J Assoc Physicians India; 1997 Nov; 45(11):883-4. PubMed ID: 11229194
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic cyproterone/ethinyloestradiol for acne.
    Lancet; 1983 Aug; 2(8347):458. PubMed ID: 6135942
    [No Abstract]   [Full Text] [Related]  

  • 19. Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.
    Seaman HE; de Vries CS; Farmer RD
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):427-36. PubMed ID: 15269926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical spinal cord infarction associated with the use of oral contraceptives for the treatment of acne in a healthy young woman.
    Meng FC; Lee JT; Peng GS; Sung YF
    J Postgrad Med; 2015; 61(1):36-7. PubMed ID: 25511216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.